[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100271986":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":13,"responsibleParty":32,"collaborators":36,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":7,"eligibilityCriteria":44,"healthyVolunteers":40,"sex":45,"minAge":46,"maxAge":7,"enrollmentInfo":47,"targetDuration":7,"studyType":50,"phases":7,"briefSummary":51,"conditions":52,"keywords":7,"overallStatus":16,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"MaineHealth","OTHER",null,[9],{"name":10,"role":11,"phone":7,"phoneExt":7,"email":12},"Joanne Burgess, RN","CONTACT","burgejs@mmc.org",[14],{"facility":15,"status":16,"city":17,"state":18,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"Maine Medical Center","RECRUITING","Portland","Maine","04102","United States","US",{"type":23,"coordinates":24},"Point",[25,26],-70.2589,43.65737,{"lat":26,"lon":25},[29],{"name":10,"role":11,"phone":30,"phoneExt":7,"email":31},"207-662-2414","BURGEJS@mmc.org",{"type":33,"investigatorFullName":34,"investigatorTitle":35,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"SPONSOR_INVESTIGATOR","Douglas B. Sawyer","Chief Academic Officer",[37],{"name":5,"class":6},"100271986","studies-of-neuregulinerbb-signaling-in-human-heart-100271986",false,"NCT02820233","Studies of Neuregulin\u002FERBB Signaling in Human Heart","Isolation and Characterization of ERBB Expressing Human Heart Progenitor Cells","Inclusion Criteria:\n\n* Clinical diagnosis of severe coronary artery disease scheduled to undergo coronary artery bypass surgery.\n\nExclusion Criteria:\n\n* less than 18 years of age\n* unwilling or unable to provide informed consent\n* known active myocarditis\n* hypertrophic cardiomyopathy\n* constrictive pericarditis or other significant pericardial disease\n* severe pulmonary hypertension\n* significant renal impairment (Cr \\> 2.5 mg\u002FdL)\n* severe ventricular arrhythmias\n* pregnancy","ALL","18 Years",{"count":48,"type":49},80,"ESTIMATED","OBSERVATIONAL","This study examines the role of the epidermal growth factor (EGF) receptor family and the EGF family of ligands in the regulation of non-myocytes isolated from the human heart.",[53,54,55],"Heart Disease","Vascular Disease","Heart Failure","2025-03-31",{"date":58,"type":59},"2025-04-03","ACTUAL",{"date":61,"type":59},"2015-06",{"date":63,"type":49},"2029-06",{"name":34,"class":6},1]